MedPath

Study of Ajmodadi churna Tablet in Diabetes.

Phase 1
Completed
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2019/07/020023
Lead Sponsor
Sumatibhai Shah Ayurved Mahavidyalaya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1.A known Diabetic on treatment and a newly diagnosed Diabetes.

2.Patient with fasting blood sugar up to 220 mg% and post prandial blood sugar up to 300 mg%.

3.Patient having HbA1C upto 10.

4.If the patient is taking ayurvedic medicine for Madhumeha, Washout period for them will be 8 days.

Exclusion Criteria

1.Patients with fasting blood sugar above 220 mg% and post prandial blood sugar above 300mg%.

2.Patient who is already taking Ayurvedic management for Madhumeha.

3.Diabetes Mellitus Type-I ,Acromegaly, Cushingââ?¬•s syndrome and pancreatic disorder.

4.Those who are under Insulin therapy.

5.Pregnant and lactating mothers.

6.Patients with acute complications like Hyperglycemic coma, Ketoacidosis and infections like gangrene.

7.Patients with K/C/O Nephropathy, Neuropathy and Retinopathy.

8.Patients with gastrointestinal diseases, Liver diseases, tumors, conditions like cardiovascular disease, acute myocardial infarction, immune-compromised disease(HIV)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)Blood sugar level Fasting and Post prandial <br/ ><br>2) HbA1cTimepoint: 3 months
Secondary Outcome Measures
NameTimeMethod
1)Blood Sugar(fasting and PP) 2) HbA1c levels. <br/ ><br>Timepoint: 3 months
© Copyright 2025. All Rights Reserved by MedPath